UMass Medical School experts share cost containment strategies at the National Association of Medicaid Directors fall conference

November 07, 2018

UMass Medical School experts will share how they can partner with Medicaid agencies to scale the cost containment summit while exhibiting in Booth #76-77 at the National Association of Medicaid Directors fall conference Nov. 12-14 in Washington, D.C.

Our team has over two decades experience supporting the Medicaid health care ecosystem, and specializes in the critical cost containment areas of eligibility determination, third-party liability and coordination of benefits, program integrity, pharmacy pipeline impact analysis, managed long-term services and supports, policy design and implementation, and evaluation and data science.

  • We are disability evaluation content experts that serve as a preferred vendor for the U.S. Social Security Administration for short term policy research and evaluation call orders. Learn more at NAMD by connecting with our Senior Director of Disability Evaluation Services Frank Joyce.

  • We realized over $68 Million in new savings over three years by optimizing benefits for Dual Eligible members. Speak with our Director of Medicare Eligibility Enhancement Programs Jenifer Hartman to learn how we can help you ensure Medicaid is the payer of last resort.

  • We conduct Medicaid provider audits focused on compliance with state and federal administrative and billing regulations. Our Center for Health Care Financing, lead by Marc Thibodeau, has a number of tools designed to help your program eradicate fraud, waste and abuse.

  • Our team identified real estate assets owned by Medicaid LTC applicants in need of assistance paying for services and saved one state $125 Million. Come talk with Marc Thibodeau to learn how we can help your program maximize cost savings through your pre-existing asset verification service.

  • More and more Medicaid agencies are obtaining demonstration waivers under Section 1115 and home- and community-based services waivers under Section 1915 (c). Our Center for Health Law and Economics Interim Director, Robert Seifert and his team can navigate the waiver processes from start to finish. We can also help states applying for Balancing Incentive Program funding.

  • The increasing frequency of new (and often high-cost) medications receiving FDA approval, means Medicaid agencies must anticipate the member and financial impact. Our pharmacy pipeline impact analysis tracks over 2,500 therapeutic agents in the late-stage pharmaceutical pipeline. Meet with our Director of Clinical Pharmacy Services, Bonnie Greenwood to learn more.

  • Our data scientists transform data into actionable information for health service delivery policymakers and program directors. We understand and address data governance and interoperability challenges and are experienced in analyzing large databases. Take precise action and gain a better understanding of your program’s impacts by sitting down with our Senior Director of Data Management Services Rick Perro.

  • As the aging population in the United States increases, Medicaid programs and their managed care partners need to take a closer look at how they are allocating resources through the long term services and supports delivery process lifecycle. Learn how our expertise, which includes clinical guideline development, member engagement and utilization management, can help your program prepare for the future from Director of National Market Development, Jocelyn Gordon.

Set up a meeting with us or learn more about our cost containment solutions.

Related Links